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Recurrent corneal erosion associated with Alport's syndrome. Ocular
defects associated with Alport syndrome (AS) include anterior lenticonus
and retinal flecks. We report on recurrent corneal erosion (RCE) as
another ocular manifestation of the disease. Three brothers with AS
reported a history of spontaneous attacks of RCE (2 episodes over I to 3
years in 2 of them and about 60 episodes in one brother over the last 10
years) characterized by acute ocular pain, lacrimation and photophobia
lasting two to five days. The absence of RCE in the two other non-affected
brothers from the same kindred suggested an association between AS and
RCE, and prompted us to assess its prevalence. Forty-one patients with
AS and renal failure and 67 control transplanted patients (with another
original nephropathy) were evaluated. Seven AS patients had a history of
RCE (first manifested between the ages of 12 and 21) versus only one
control patient (P = 0.003). In conclusion, a history of RCE is found in
about 20% of patients with AS and renal failure. RCE is likely to result
from an inherent structural weakness of the corneal epithelial basement
membrane (containing type IV collagen). A history of RCE should he
sought when evaluating a patient for AS. Ophthalmologists should also be
aware of this association, when confronted with a patient suffering from
non-traumatic RCE.
Alport's syndrome (AS) is a genetic disease of basement
membranes clinically characterized by progressive glomerulopa-
thy variably associated with sensorineural hearing loss and ocular
defects [1, 21. In about 85% of AS pedigrees, the disease is
X-linked and mutations identified so far are in the cs5 (IV)
collagen chain gene (COL4A5) [2, 3]. In the vast majority of the
remaining families, the transmission is autosomal recessive with
mutations detected in the genes coding cs3 (IV) and a4 (IV)
collagen chains [41.
Ocular abnormalities, reported in 15 to 30% of patients with AS
classically include anterior lenticonus and retinal flecks in the
macular and mid-peripheral retina [2, 5, 6]. We here describe the
occurrence of non-traumatic recurrent corneal erosion (RCE) as
a further ocular manifestation of AS.
RCE are manifest by attacks of acute ocular pain, photophobia
and a tearing sensation, often at the time of awakening [7]. RCE
may occur after trauma or in association with corneal dystrophy
[7].
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We have observed RCE in three brothers suffering from
juvenile X-linked AS, whereas ocular symptoms were lacking in
their two non-affected brothers. This observation suggested an
association between these two conditions. We therefore con-
ducted a survey in a group of AS patients and controls, which
confirmed the association.
METHODS
The three brothers with AS whose history is detailed belong to
a kindred of five males, two of whom are non-affected. Their
mother was found to have microhaematuria. In this family, AS
was proven to be linked to the COL4A5 locus.
Forty-one other patients (34 males, 7 females) belonging to 28
families with a clear diagnosis of AS and followed at Cliniques St.
Luc were eligible for the study. Diagnosis of AS relied on the
association of (1) a history of hematuria and renal failure, (2)
typical bilateral sensorineural deafness, and (3) a family history of
nephritis or characteristic ultrastructural aspect of the glomerular
basement membrane. Thirty-eight patients had reached end-stage
renal failure (ESRF) (33 before the age of 31 years, 5 after the age
of 31 years) and had been transplanted. Three patients (from 3
different families) were found to have a deletion in the COL4A5
gene and one had a homozygous single-base substitution in the
COL4A3 gene [4]. The disease was found to be linked to the
COL4A5 gene in seven other families. Pedigree and history
were compatible with an X-linked or an autosomal recessive
inheritance in an additional 10 and 4 families, respectively. The
type of AS was undefined in the three remaining families
(Table I).
The control group consisted of 67 transplanted patients (36
males, 31 females) aged 13 to 50 (mean 37) years with another
original nephropathy who were consecutively seen at our outpa-
tients clinic.
Patients and controls were questioned in detail about past
ophthalmological history, with a special reference to the symp-
toms of corneal erosions. A result was positive if two or more
episodes of eorneal erosions had occurred (confirmed at least
once by an ophthalmologist) necessitating treatment.
Full ophthalmological examination was performed on patients
giving a positive result.
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Table 1. Prevalence of recurrent corneal erosion in a group of 41
patients with Alport's syndrome
ASType
Familes
N
Patients
N
RCE
N
X-linked
Deletion COL4A5 3 3 1
Linkage COL4A5 7 13 1
Pedigree compatible 10 13 3
Autosomal recessive
Mutation COL4A3 1 1 0
Pedigree compatible 4 5 1
Undefined 3 6 1
Total 28 41 7
RESULTS
Case reports
Case 1. A 23-year-old man diagnosed with juvenile X-linked AS
with a proven linkage to COL4A5 initially presented at age three
when microhaematuria coincided with a febrile illness. Increas-
ing sensorineural deafness became apparent during primary
education; a hearing aid was prescribed when he was age 14. A
decline in renal function began at age 17, and he reached ESRF
at 19. He was successfully transplanted with a cadaveric kidney
and graft function is currently normal (creatinine clearance 76
ml/min).
Ocular complaints began during the pre-transpiant work-up,
when he was 19-years-old. A red, painful "watery eye" with a
foreign body sensation developed spontaneously; ophthalmologi-
cal examination showed an extensive unilateral corneal erosion,
needing an occlusive patch for three days. The second major
attack appeared some months later after skiing without goggles. It
should be noted that bicycle riding and lack of sleep provoke
minor attacks, which can affect either eye. Furthermore, if morn-
ing eye opening is painful, then it is necessary to keep his eyes
closed for an extra hour to avoid redness and pain. Contact lenses
are poorly tolerated and can only be worn for 12 hours over a
three day period. No evidence of retinal flecks, lenticonus, or
corneal abnormality were seen at the most recent ophthalmolog-
ical examination.
Case 2. The eldest brother of case 1, a 24-year-old man, had
presented aged 2.5 years with fever and gross hematuria. By the
age of 9, a hearing deficit was evident. The decline in renal
function began when he was age 19, reaching the present preter-
minal stage (serum creatinine 8 mg/dl).
His ocular problems began at age 14, when symptoms of acute
ocular pain and a red eye were found by an ophthalmologist to be
due to a corneal erosion. Since then, he has suffered repeated
episodes every two months or so, affecting either eye, and only
once attack being bilateral. A typical attack involves an acutely
painful red eye, with increased lacrimation and photophobia, with
symptoms lasting up to five days. He has identified the following
precipitating factors: working at a computer screen, prolonged
reading and motorbike rides without eye protection. Five episodes
needed treatment with an occlusive eye patch and antibiotic
ointment. Attempts to reduce the intensity and duration of an
attack using antiseptic drops are of variable benefit. His most
recent ophthalmological examination showed retinal flecks and
rare corneal epithelial microcysts but no evidence of anterior
lenticonus.
Case 3. The youngest affected brother of the first two cases, a
21-year-old man, first presented with microhematuria and
proteinuria when he was age seven. Hearing deficit was evident
and a hearing aid was prescribed at age 8. Renal function has
declined since the age of 16, reaching ESRF by the age of 20.
He is currently treated by continuous ambulatory peritoneal
dialysis.
His ocular problems began when he was 19-years-old, when he
had had two episodes of corneal erosions. Initial symptoms were
after a prolonged period of computer work when the right eye
became dry and he felt a foreign body sensation, similar to grains
of sand in his eye. Blinking provoked a sharp tearing pain and
photophobia. He sought no medical advice and the pain disap-
peared after two days. No obvious precipitating factors preceded
the second major episode, for which he underwent ophthalmo-
logical evaluation after four days of acute ocular pain and
lacrimation. Examination revealed a red right eye due to a corneal
erosion associated with a detached epithelial flap and stromal
edema. An occlusive dressing, topical antibiotics, atropine eye
drops and codeine analgesia were prescribed. Daily follow-up for
seven days confirmed complete resolution of symptoms and signs.
Recent ophthalmological examination revealed retinal flecks and
rare corneal epithelial microcysts but absence of lenticonus.
Other family members
The mother, aged 49, who is a carrier of AS, and her two other
sons (aged 20 and 18), who are unaffected, have no history of
corneal erosion and no abnormality at recent ophthalmological
examination.
Survey
Seven out of 41 AS patients were found to suffer from RCE.
Five were males with juvenile (defined as ESRF before the age of
31) X-linked AS, one was a female with most likely an autosomal
recessive AS, and the last one a male with an undefined form of
AS (Table 1). In all cases RCE had not been previously recog-
nized by their nephrologist. Ages of onset varied between 12 and
19 years with art average of 17 years (Table 2). The number of
episodes experienced ranged from 2 to over 60. These seven
patients belonged to seven different families. Three of them had
one relative with AS (all males and in ESRF) but without a history
of RCE. Full ophthalmological examination showed retinal flecks
and anterior lenticonus each in four patients, sometimes sepa-
rately (Table 2). At a distance from the erosion, cornea appeared
completely normal in three patients and showed rare intraepithe-
hal microcysts in the four others, and with, in addition, unilateral
endothelial dystrophy in one of them.
Another male with juvenile X-linked AS presented with a single
documented episode of non-traumatic corneal erosion. Four
other males, also with juvenile X-linked AS, described an in-
creased sensitivity of the eyes to wind exposure or to bright light,
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Table 2. Characteristics of the 10 patients with Alport's syndrome and
a histoiy of recurrent cornea! erosion
RCE
Patient Sex
Age at
ESRD -_Lenticonus
Retinal
flecks
Age at
onset
Number
of attacks
Casel M 19 — — 19 2
Case2 M — — + 14 60
Case3 M 20 — + 19 2
TL M 17 + + 17 40
MB M 22 + — 16 40
PD M 12 + + 12 60
GP M 20 — — 18 20
RB M 19 + + 21 2
SC F — — — 19 4
AD M 23 - + 18 6
with symptoms frequently occurring after awakening; however,
evidence of cornea! erosion was lacking.
Among the 67 control patients, only one (with IgA nephropa-
thy) reported a history compatible with RCE, which is a signifi-
cantly lower rate than in the AS group (P = 0.003).
DISCUSSION
Our data clearly demonstrate the association of RCE with AS.
A diagnosis of RCE was established in the three brothers with
juvenile X-linked AS. The absence of RCE in their two unaffected
brothers together with the absence of known etiological factors
(corneal trauma and cornea! dystrophy) and the bilateral nature
of the affliction strongly supported an association between RCE
and AS. Further evidence of an association between the two
conditions comes from the results of our survey where 7 out of 41
AS patients from 28 families who suffered from RCE, giving a
local prevalence of 17% (23% if we include the 3 brothers from
index family), for a condition that is very unusual both in the
general population and in ESRD patients with another nephrop-
athy.
All affected patients described typical episodes of RCE trig-
gered by outdoor activity during windy conditions, lack of sleep,
long periods of ocular concentration and use of contact lenses.
The average age at the time of initial episode of RCE was 17 years
and the number of total attacks varied between 2 to 60. In our
patients, symptoms included acute tearing pain in the eyes upon
awakening, redness, increased lacrimation, foreign body sensation
and photophobia. Length of attacks varied between five hours and
five days, and all patients described eye closure or an occlusive eye
patch as having a soothing effect. Preventative measures taken by
affected patients included an avoidance of windy conditions or of
prolonged reading, and a preference for spectacles over contact
lenses.
It should be noted that for the survey we selected patients with
the most severe presentation of AS, namely with deafness and
renal failure. Whether or not RCE is restricted to this pheno-
type cannot he answered by our study. Interestingly, a history of
RCE did not correlate with the presence of lenticonus or
retinal flecks.
The convincing association between AS and RCE seen in the
family of three brothers described suggest that this association
resulted from their specific mutation in the COL4A5 gene.
However, each of three other surveyed patients with AS and RCE
have one relative with AS and renal failure but without a history
of RCE. Thus, other factors such as environmental agents also
play a role in the occurrence of RCE.
Our findings explain the occasional association of RCE and AS
previously reported in two patients [8, 9]. One may wonder why
the prevalence of RCE in AS has not been previously reported. It
is worth noting that, in our series, neither the symptoms nor the
signs of RCE had been recorded in the nephrology notes,
indicating that this association has been previously underesti-
mated.
Composition of corneal basement membranes may readily
account for an association of AS with RCE. The basement
membrane complex keeping the cornea! epithelial cells adherent
to the underlying stroma indeed consists of type IV collagen [71
containing the a3, a4 and a5 chains [10, 11]. Just as in glomerulus
[2] and lens [12], a structural defect in the cs3/cs4/a5 chain could
prevent or disturb the formation of cs3-a4-cs5 heterotrimers in the
cornea epithelia! basement membrane and thus result in an
increased fragility facilitating RCE. Slit lamp examination with
fluorescein dye may confirm localized abrasion of the cornea!
epithelium and reveal a detached epithelial flap. As in other forms
of RCE, examination between erosion episodes inconstantly
shows nonspecific epithelial microcysts [7]. Interestingly, Teekha-
saenee et a! described an association between posterior polymor-
phous dystrophy and AS [13]. Such an association is also sup-
ported by the localization of the cs3lcs4lcs5 (IV) chains in the
cornea! Descemet membrane (which is deep to the epithelial
basement membrane). Only one of our patients had evidence of
such a corneal dystrophy.
On a practical level, a history of RCE may act as a pointer to
AS. Noteworthy, in two of the affected patients, the RCE were
apparent before the diagnosis of AS was made. Ophthalmologists
should be aware of this association when confronted with a patient
suffering from non-traumatic RCE, as should nephro!ogists when
investigating a young patient for microscopic hematuria.
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